v3.26.1
SEGMENT INFORMATION
 3 Months Ended
Apr. 03, 2026
Segment Reporting [Abstract]  
SEGMENT INFORMATION NOTE 10. SEGMENT INFORMATION
We report our results in two separate business segments consisting of Intelligent Operating Solutions and Advanced Healthcare Solutions. We determine our business segments based on the identification of segment managers and similarities in products, end markets, economic characteristics, technologies, and services, as well as the financial data utilized by the Company's chief executive officer. The Company's chief operating decision maker ("CODM") is the chief executive officer.
The CODM uses gross profit and operating profit at the segment level to assess performance and allocate resources, including those associated with merger and acquisition targets. The CODM also compares the actual results to expectations in assessing the performance of the segments. Operating expenses generally include selling, general and administrative expenses, and research and development expenses. Depreciation expense is allocated between Cost of sales and Selling, general, and administrative expenses. Amortization expense is recorded within Selling, general, and administrative expenses. The identifiable assets by segment are those used in each segment’s operations. Inter-segment amounts are not significant and are eliminated in the combined totals. Unallocated costs and other costs are not considered part of our evaluation of reportable segment operating performance.
Segment results for the three months ended April 3, 2026 are shown below ($ in millions):
Total
Intelligent Operating Solutions
Advanced Healthcare Solutions
Unallocated Corporate Costs and Other
Sales
$1,069.4 $743.2 $326.2 $— 
Cost of sales
(393.9)(259.4)(134.5)— 
Gross profit
675.5 483.8 191.7 — 
Operating expenses
(483.8)(297.6)(159.0)(27.2)
Operating profit (loss)
191.7 186.2 32.7 (27.2)
Non-operating income (expense), net
Interest expense, net
(31.6)— — (31.6)
Other non-operating income (expense), net
3.5 — — 3.5 
Earnings from continuing operations before income taxes
$163.6 $186.2 $32.7 $(55.3)
Depreciation and amortization expenses
$(113.6)$(62.4)$(50.8)$(0.4)
Capital expenditures
$(26.6)$(20.7)$(5.9)$— 
Segment results for the three months ended March 28, 2025 are shown below ($ in millions):
Total
Intelligent Operating Solutions
Advanced Healthcare Solutions
Unallocated Corporate Costs and Other
Sales
$993.1 $690.9 $302.2 $— 
Cost of sales
(355.6)(231.5)(124.1)— 
Gross profit
637.5 459.4 178.1 — 
Operating expenses
(472.2)(284.8)(156.4)(31.0)
Operating profit (loss)
165.3 174.6 21.7 (31.0)
Non-operating income (expense), net
Interest expense, net
(32.0)— — (32.0)
Other non-operating income (expense), net
0.4 — — 0.4 
Earnings from continuing operations before income taxes
$133.7 $174.6 $21.7 $(62.6)
Depreciation and amortization expenses
$(108.0)$(58.2)$(49.5)$(0.3)
Capital expenditures
$(21.1)$(16.9)$(4.0)$(0.2)
Segment Assets:
As of
($ in millions)April 3, 2026December 31, 2025
Intelligent Operating Solutions$6,287.6 $6,346.0 
Advanced Healthcare Solutions4,798.2 4,861.6 
Total segment assets11,085.8 11,207.6 
Other (a)
493.5 509.3 
Assets of Discontinued Operations4.8 20.8 
Total assets$11,584.1 $11,737.7 
(a) Other represents corporate assets which consist primarily of cash, property, plant, and equipment, and net deferred income tax assets.